Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant

Clinical trial NCT04425226 · UNKNOWN

Trial details

NCT number: NCT04425226
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Transplant; Complications Hepatocellular Carcinoma Recurrent

Start date: 2020-08-06
Primary completion: 2022-12-30
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.